Lvkang Biochemical sells 90.0003% stake in Lvan Bio for 31.58 million yuan

Corporate Action
โดย Jiemian·CN·Read original
Summary · why it matters

Lvkang Biochemical Co., Ltd. announced that it has formally signed an equity transfer agreement and supplementary agreement with the transferee Shanxi Xinyuan Huakang Biotechnology Co., Ltd., the other shareholder of Fujian Lvan Biopesticide Co., Ltd., Jiubailiu Beijing Technology Co., Ltd., and Lvan Bio regarding the sale of a 90.0003% stake in Fujian Lvan Biopesticide Co., Ltd. The entire equity of Lvan Bio is valued at 35.09 million yuan, corresponding to a transaction price of 31.5811 million yuan for the company's 90.0003% stake. The matter was approved at the 38th interim meeting of the company's fifth board of directors on August 18, 2026. After the transaction is completed, the company will no longer hold any equity in Lvan Bio. The company cautioned that the equity transfer still requires the counterparty to pay the consideration under the agreement and complete the equity transfer registration procedures, and there is uncertainty as to whether it can ultimately be implemented successfully.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 3

福建绿安生物农药有限公司Private± Mixed
Capitalrelevance

Company is the subject of the stake sale, but impact depends on new ownership.

山西新源华康生物科技股份有限公司Private± Mixed
Capitalrelevance

Buyer of the stake, but terms and strategic intent not detailed.

玖佰陆拾（北京）科技有限公司Private± Mixed
relevance

© 2026 MarketDXNews